• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
  • Podcasts
  • Resources
    • Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
  • Podcasts
  • Resources
    • Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

Ocugen

Biotech

Ocugen COVID shot will have to wait for US market after FDA hold

Ocugen revealed in the early morning hours after Thanksgiving that the FDA placed a clinical hold on its COVID-19 vaccine. 
Kyle LaHucik Nov 29, 2021 11:27am

Ocugen climbs on phase 3 COVID vaccine data

Jul 6, 2021 9:30am

Ocugen preps dry eye disease drug for phase 3

Mar 20, 2018 10:18am

Aeterna review, Allegro eye test and Ocugen orphan tag—News of Note

Aug 9, 2017 9:46am

Chutes & Ladders—BIO elects John Maraganore as new chair

Jun 22, 2017 4:08pm

Eye specialist Ocugen looks east for second-round fundraising

Jun 15, 2017 9:42am
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
  • ©2022 Questex LLC All rights reserved.
  • Terms of use
  • Privacy Policy